Axcella Announces Interim Data From Phase 2b EMMPACT Study Of AXA1125 In Nonalcoholic Steatohepatitis
September 29, 6:06 AM
Subjects enrolled with biopsy confirmed NASH experienced clinically and statistically significant improvements in liver stiffness as measured by FibroScan, a non-invasive measure of liver fibrosis Subjects with
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday’s Mid-Day Session
September 19, 12:29 PM
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
September 19, 10:05 AM
Axcella Health's (NASDAQ:AXLA) short percent of float has fallen 8.62% since its last report. The company recently reported that it has 96 thousand shares sold short, which is 0.53% of all regular shares that are available for trading.